First-Line Treatment for HIV-2

NCT02150993 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

210

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-2 Infection

Interventions

DRUG: Tenofovir + Emtricitabine or Lamivudine + Zidovudine
DRUG: Tenofovir + Emtricitabine or Lamivudine + Lopinavir/ritonavir
DRUG: Tenofovir + Emtricitabine or Lamivudine + Raltegravir

Sponsor

ANRS, Emerging Infectious Diseases